THE INDIAN PHARMA STORY
India would play an important role in working out cost efficient ways of developing new drugs Stephen Cutler COO, Kendle
Compound Annual Growth Rate (CAGR) of 16%
Indian pharmaceutical sector accounts for 2.4% of the global pharmaceutical industry in value terms and 10% in volume terms.
- It is growing at a Compound Annual Growth Rate (CAGR) of 16%. It is likely to touch a market size of US $100 billion by 2025.
World's leader in Drug Master Files
India is the third-largest global generic Active Pharmaceutical Ingredient (API) merchant market.
-
The country accounts for the second largest number of Abbreviated New Drug Applications (ANDAs) and is the world's leader in Drug Master Files. (DMFs) applications with the US.
Largest provider of generic medicines globally.
Indian drugs are exported to more than 200 countries in the world, with the USA as its main market.
-
Generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally. This is expected to expand even further in coming years.
Acquired Immuno Deficiency Syndrome
India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have
-
the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.
(USFDA)
Overall drug approvals given by the US Food and Drug Administration (USFDA) to Indian companies have nearly doubled to 201 in FY 2015-16 from 109 in FY 2014-15.
-
The country accounts for around 30 per cent (by volume) and about 10 per cent (value) of the US$ 70-80 billion US generics market.
US $100 billion by 2025
India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture, bio-industry and bioinformatics is expected to grow at an average growth rate of around 30 percent a year and reach US$ 100 billion by 2025.
-
.